NVRO Nov 2024 10.000 put
- PR Newswire
Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08
Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, announced that on June 7, 2024, the Compensation Committee of the Company's Board of Directors granted inducement restricted stock unit awards covering 56,692 shares of Nevro's common stock to 17 new non-executive employees to induce them to accept employment with Nevro. Each award was granted under the Nevro Corp. 2023 Inducement Award Plan and v
- PR Newswire
Nevro to Present at Truist Securities MedTech Conference
Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced that members of its management team will participate in a "fireside chat" (question-and-answer) session at the Truist Securities MedTech Conference on Tuesday, June 18, 2024, beginning at approximately 8:40 am EDT.
- Zacks
Why Is Nevro (NVRO) Down 8.8% Since Last Earnings Report?
Nevro (NVRO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
